TQQQ:NSD-ProShares UltraPro QQQ (USD)

ETF | Trading--Leveraged Equity |

Last Closing

USD 88.25

Change

-0.19 (-0.21)%

Market Cap

USD 27.82B

Volume

0.03B

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

The fund invests in financial instruments that ProShare Advisors believes, in combination, should produce daily returns consistent with the Daily Target. The index includes 100 of the largest domestic and international non-financial companies listed on The Nasdaq Stock Market based on market capitalization. The fund is non-diversified.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-12-26 )

Largest Industry Peers for Trading--Leveraged Equity

Symbol Name Price(Change) Market Cap
BIB ProShares Ultra Nasdaq Biotech..

+0.58 (+1.11%)

USD 0.08B

ETFs Containing TQQQ

ULTY Tidal Trust II 5.76 % 0.00 %

N/A

USD 0.29B
GTAA 0.00 % 1.25 %

N/A

N/A
HUSE 0.00 % 0.91 %

N/A

N/A
QQH HCM Defender 100 Index ET.. 0.00 % 0.00 %

+0.01 (+0.00%)

USD 0.58B

Market Performance

  Market Performance vs. Industry/Classification (Trading--Leveraged Equity) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 74.06% 100% F 90% A-
Dividend Return 1.98% 100% F 37% F
Total Return 76.04% 100% F 90% A-
Trailing 12 Months  
Capital Gain 71.66% 100% F 90% A-
Dividend Return 1.95% 100% F 37% F
Total Return 73.61% 100% F 90% A-
Trailing 5 Years  
Capital Gain 302.00% 100% F 95% A
Dividend Return 7.93% 100% F 27% F
Total Return 309.94% 100% F 95% A
Average Annual (5 Year Horizon)  
Capital Gain 51.17% 100% F 87% B+
Dividend Return 51.99% 100% F 87% B+
Total Return 0.81% 100% F 23% F
Risk Return Profile  
Volatility (Standard Deviation) 91.78% 50% F 23% F
Risk Adjusted Return 56.64% 100% F 81% B-
Market Capitalization 27.82B 100% F 97% N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

High dividend returns

The stock has outperformed its sector peers on average annual dividend returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile. This can be a good buy, especially if it is outperforming on total return basis , for investors seeking high income yields.

Superior total returns

The stock has outperformed its sector peers on average annual total returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile.

High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

What to not like:
High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.